Pilot randomized trial on mindfulness training for smokers in young adult binge drinkers.

Journal Article

We report results of a pilot study designed to test a novel smoking cessation intervention, Mindfulness Training for Smokers (MTS), in smokers age 18-29 years with regular episodes of binge drinking. Mindfulness is a cognitive skill of applying close moment-to-moment attention to experience with a mental posture of acceptance and non-reactivity. The MTS intervention consisted of six weekly classes that provided instruction on how to use mindfulness to manage known precursors of smoking relapse including smoking triggers, strong emotions, stressful situations, addictive thoughts, urges, and withdrawal symptoms.The MTS intervention was compared to Interactive Learning for Smokers (ILS), a time/intensity matched control group using daily non-directed walking instead of mindfulness meditation. Recruitment was conducted primarily at local technical colleges. Primary outcome measures included biochemically-confirmed smoking abstinence and reduction in alcohol use at the end of treatment (2-weeks post-quit attempt).The sample (N = 55) was 70.9% male, with a mean age of 21.9 years, and a mean of 11.76 alcoholic drinks consumed per week. Intent-to-treat analysis showed biochemically-confirmed 7-day point prevalence abstinence rates at 2-weeks post-quit for MTS = 20.0% and ILS = 4.0%, p = .08. Secondary analysis showed number of drinks per week in the first 2-weeks post-quit correlated with smoking relapse at 2-weeks post-quit (p < .01).This pilot study demonstrated that Mindfulness Training for Smokers shows promise for smoking cessation and alcohol use reduction in treating young adult smokers with alcohol abuse. Results suggest the need for a study with larger sample size and methods that reduce attrition.ClnicalTrial.gov, NCT01679236.

Full Text

Duke Authors

Cited Authors

  • Davis, JM; Mills, DM; Stankevitz, KA; Manley, AR; Majeskie, MR; Smith, SS

Published Date

  • September 3, 2013

Published In

Volume / Issue

  • 13 /

Start / End Page

  • 215 -

PubMed ID

  • 24006963

Electronic International Standard Serial Number (EISSN)

  • 1472-6882

International Standard Serial Number (ISSN)

  • 1472-6882

Digital Object Identifier (DOI)

  • 10.1186/1472-6882-13-215

Language

  • eng